NANOBIOTIX denies takeover rumors

NANOBIOTIX, a French-American biotechnology company, has responded to rumors of a takeover bid. The company, listed on Euronext and NASDAQ, asserts that no such project or evaluation currently exists. It also points out inaccuracies in the information reported by this media outlet, which contradict recent publicly available data.

NANOBIOTIX is distinguished by its innovations in cancer treatment, based on the use of nanoparticles. The company attributes these rumors to misinterpretation or misinformation and remains committed to pursuing its advanced clinical development without disruption.